filmov
tv
antibody drug conjugates
0:01:44
What are antibody-drug conjugates and how do they work against cancer?
0:27:03
Antibody Drug Conjugates: The end of chemotherapy | 2023 West Oncology Conference
0:03:34
Targeting tumours: Challenges of antibody-drug conjugates
0:01:17
Sanofi – Antibody – Drug Conjugates
0:00:58
How Does It Work? | Antibody Drug Conjugates
0:01:42
What are Antibody Drug Conjugates (ADCs)?
0:05:57
Antibody Drug Conjugates: Characterization
0:30:15
[Webinar] Manufacturing concepts for antibody-drug conjugates | Webinar
0:01:42
Overcoming resistance to trastuzumab deruxtecan in HER2-low cancers
0:08:45
How Are Antibody Drug Conjugates Used to Treat Breast Cancer? All You Need to Know
0:03:10
How antibody-drug conjugates work
1:21:32
Antibody–Drug Conjugates for Solid Tumors: Progress, Possibilities, and Implications for Care
0:04:18
Antibody Conjugates: What You Need to Know | CST Tech Tips
0:01:01
Antibody drug conjugates: science and imagination linked by purpose
0:02:26
Therapeutic antibodies (Part 3): antibody-drug conjugates
0:07:12
Brief Introduction of Antibody Drug Conjugates - BOC Sciences
0:25:46
Antibody Drug Conjugates Present and Future Applications in Breast Cancer
0:02:34
Antibody Drug Conjugates
0:01:47
What are antibody-drug conjugates and how do they work against cancer? (Estonian version)
0:03:35
Understanding Antibody Drug Conjugates
0:46:10
Targeted Cancer Chemotherapy: Developing NextGen Antibody-Drug Conjugates
0:06:22
What are antibody drug conjugates?
0:01:47
Antibody-drug Conjugate-Precision Targeted Therapy - Creative Biolabs
0:01:33
Antibody-drug conjugates (ADCs) in NSCLC
Вперёд